Legal & General Group PLC Aurinia Pharmaceuticals Inc. Transaction History

Legal & General Group PLC

$431 Billion
Q3 2025

A detailed history of Legal & General Group PLC transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 140,991 shares of AUPH stock, worth $2.16 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

140,991

Previous 141,492 0.35%

Holding current value

$2.16 Million

Previous $1.2 Million 29.97%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	SELL	$7.47 - $13.14 $3,742 - $6,583	-501 Reduced 0.35%	140,991 $1.56 Million
Q2 2025 Aug 12, 2025	BUY	$7.2 - $8.64 $144,194 - $173,033	20,027 Added 16.49%	141,492 $1.2 Million
Q1 2025 May 15, 2025	SELL	$7.55 - $8.77 $74,299 - $86,305	-9,841 Reduced 7.49%	121,465 $976,000
Q4 2024 Feb 13, 2025	SELL	$6.75 - $10.44 $33,196 - $51,343	-4,918 Reduced 3.61%	131,306 $1.18 Million
Q3 2024 Feb 28, 2025	SELL	$5.32 - $7.33 $18,226 - $25,112	-3,426 Reduced 2.61%	127,880 $937,000

Q3 2024 Nov 14, 2024	SELL	$5.32 - $7.33 $5,878 - $8,099	-1,105 Reduced 0.8%	136,224 $998,000
Q2 2024 May 29, 2025	SELL	$4.81 - $5.78 $13,342 - $16,033	-2,774 Reduced 2.11%	128,985 $736,000
Q2 2024 Aug 14, 2024	BUY	$4.81 - $5.78 $26,791 - $32,194	5,570 Added 4.23%	137,329 $784,000
Q1 2024 May 29, 2025	BUY	$4.93 - $9.31 $50,749 - $95,837	10,294 Added 8.47%	131,759 $660,000
Q1 2024 May 14, 2024	SELL	$4.93 - $9.31 $4,121 - $7,783	-836 Reduced 0.63%	131,759 $660,000
Q4 2023 May 29, 2025	BUY	$7.13 - $9.49 $79,356 - $105,623	11,130 Added 9.16%	132,595 $1.19 Million
Q4 2023 Feb 15, 2024	BUY	$7.13 - $9.49 $11,108 - $14,785	1,558 Added 1.19%	132,595 $1.19 Million
Q3 2023 Nov 14, 2023	BUY	$7.77 - $12.27 $57,583 - $90,932	7,411 Added 5.99%	131,037 $1.02 Million
Q2 2023 Aug 14, 2023	BUY	$8.96 - $11.69 $2,965 - $3,869	331 Added 0.27%	123,626 $1.2 Million
Q1 2023 May 15, 2023	BUY	$5.94 - $11.27 $27,549 - $52,270	4,638 Added 3.91%	123,295 $1.35 Million
Q4 2022 Feb 14, 2023	BUY	$4.11 - $8.14 $7,714 - $15,278	1,877 Added 1.61%	118,657 $512,000
Q3 2022 Nov 14, 2022	SELL	$6.66 - $12.39 $66,147 - $123,057	-9,932 Reduced 7.84%	116,780 $878,000
Q2 2022 Aug 22, 2022	BUY	$8.95 - $12.8 $325,627 - $465,702	36,383 Added 40.28%	126,712 $1.27 Million
Q1 2022 May 16, 2022	BUY	$10.05 - $22.48 $547,875 - $1.23 Million	54,515 Added 152.22%	90,329 $1.12 Million
Q4 2021 Feb 14, 2022	SELL	$17.78 - $33.08 $76,418 - $142,177	-4,298 Reduced 10.71%	35,814 $819,000
Q3 2021 Nov 15, 2021	BUY	$10.93 - $23.55 $381,249 - $821,447	34,881 Added 666.81%	40,112 $841,000
Q3 2020 Nov 13, 2020	BUY	$13.19 - $16.66 $18,848 - $23,807	1,429 Added 37.59%	5,231 $77,000
Q4 2019 Feb 13, 2020	BUY	$3.88 - $21.42 $5,754 - $31,765	1,483 Added 63.95%	3,802 $77,000
Q1 2019 May 15, 2019	BUY	$6.06 - $7.64 $14,053 - $17,717	2,319 New	2,319 $15,000
Q3 2018 Nov 20, 2018	SELL	$5.27 - $6.64 $12,273 - $15,464	-2,329 Closed	0 $0
Q1 2018 May 17, 2018	BUY	$4.85 - $5.99 $11,295 - $13,950	2,329 New	2,329 $12,000

Others Institutions Holding AUPH

# of Institutions

269

Shares Held

69.3M

Call Options Held

984K

Put Options Held

574K

View Full List

About Aurinia Pharmaceuticals Inc.

Ticker AUPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,892,000
Market Cap $2.18B
Description
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...

More about AUPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Account

Legal & General Group PLC Aurinia Pharmaceuticals Inc. Transaction History